Ticker

OCGN

Ocugen, Inc.

7 catalysts on file

OCGN

Ocugen, Inc.

Phase 2 Confirmed

OCU410

Geographic Atrophy (late-stage dry AMD)

218d ago Jan 15, 2026

SEC 8-K verified 2mo ago

Countdown card →

OCGN

Ocugen, Inc.

Phase 1 Confirmed

OCU410

geographic atrophy secondary to dry age-related macular degeneration

218d ago Jan 15, 2026

SEC 8-K verified 2mo ago

Countdown card →

OCGN

Ocugen, Inc.

Phase 2 AI-extracted

OCU400

Retinitis Pigmentosa

148d ago Mar 26, 2026

SEC 8-K verified 2mo ago

Countdown card →

OCGN

Ocugen, Inc.

Phase 1 AI-extracted

OCU400

Retinitis Pigmentosa

148d ago Mar 26, 2026

SEC 8-K verified 2mo ago

Countdown card →

OCGN

Ocugen, Inc.

Phase 3 AI-extracted

OCU410

Geographic Atrophy

T-minus 40 days ~ Sep 30, 2026

SEC 8-K verified 2mo ago

Countdown card →

OCGN

Ocugen, Inc.

Phase 3 AI-extracted

OCU400

Retinitis Pigmentosa

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

Countdown card →

OCGN

Ocugen, Inc.

CRL AI-extracted

OCU400

Retinitis Pigmentosa

Date TBD Date TBD

SEC 8-K verified 2mo ago

Countdown card →